Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Small

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Cancer|August 1, 1993
Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin diseaseE J Small, A P Venook, L E Damon
Cancer Investigation|October 17, 1998
Pyrazoloacridine for the treatment of hormone-refractory prostate cancerE J Small, L J Fippin, S P Whisenant
Cancer|June 15, 1985
Malignant rhabdoid tumor of the heart in an infantE J Small, G J Gordon, B B Dahms
Pediatric Pathology|January 1, 1986
Dual origin of the left coronary artery with vestigial branch arising from the aorta and main trunk arising from the pulmonary arteryE J Small, M C Sivakoff, B B Dahms
Journal of Neuropathology and Experimental Neurology|September 1, 1987
Neuropathology of "septo-optic dysplasia" (de Morsier syndrome) with immunohistochemical studies of the hypothalamus and pituitary glandU Roessmann, M E Velasco, E J Small, et al.
The Journal of Urology|April 1, 1997
Ketoconazole retains activity in advanced prostate cancer patients with progression despite flutamide withdrawalE J Small, A D Baron, L Fippin, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|February 7, 2004
The evolving role of androgen deprivation therapy in the management of prostate cancerM R Cooperberg, E J Small, A D'Amico, et al.
The British Journal of Radiology|September 4, 1999
Diffuse retroperitoneal amyloidosis due to renal cell carcinomaF V Coakley, H Hricak, J C Presti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
Is the use of anti-androgen monotherapy appropriate in patients with advanced prostate cancer?M Roach, D Reese, V Weinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Doxorubicin and dose-escalated cyclophosphamide with granulocyte colony-stimulating factor for the treatment of hormone-resistant prostate cancerE J Small, S Srinivas, B Egan, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Cancer|August 1, 1993
Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin diseaseE J Small, A P Venook, L E Damon
Cancer Investigation|October 17, 1998
Pyrazoloacridine for the treatment of hormone-refractory prostate cancerE J Small, L J Fippin, S P Whisenant
Cancer|June 15, 1985
Malignant rhabdoid tumor of the heart in an infantE J Small, G J Gordon, B B Dahms
Pediatric Pathology|January 1, 1986
Dual origin of the left coronary artery with vestigial branch arising from the aorta and main trunk arising from the pulmonary arteryE J Small, M C Sivakoff, B B Dahms
Journal of Neuropathology and Experimental Neurology|September 1, 1987
Neuropathology of "septo-optic dysplasia" (de Morsier syndrome) with immunohistochemical studies of the hypothalamus and pituitary glandU Roessmann, M E Velasco, E J Small, et al.
The Journal of Urology|April 1, 1997
Ketoconazole retains activity in advanced prostate cancer patients with progression despite flutamide withdrawalE J Small, A D Baron, L Fippin, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|February 7, 2004
The evolving role of androgen deprivation therapy in the management of prostate cancerM R Cooperberg, E J Small, A D'Amico, et al.
The British Journal of Radiology|September 4, 1999
Diffuse retroperitoneal amyloidosis due to renal cell carcinomaF V Coakley, H Hricak, J C Presti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
Is the use of anti-androgen monotherapy appropriate in patients with advanced prostate cancer?M Roach, D Reese, V Weinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Doxorubicin and dose-escalated cyclophosphamide with granulocyte colony-stimulating factor for the treatment of hormone-resistant prostate cancerE J Small, S Srinivas, B Egan, et al.
Pageof 9